Evidence map›Paper›PMID 29753885›Full record

ReviewCurrent opinion in immunology2018

Immunological responses to influenza vaccination: lessons for improving vaccine efficacy.

Taia T Wang, Stylianos Bournazos, Jeffrey V Ravetch

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Taia T WangStanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA.
Stylianos BournazosThe Rockefeller University, 1230 York Avenue, NY 10065, USA.
Jeffrey V RavetchThe Rockefeller University, 1230 York Avenue, NY 10065, USA. Electronic address: ravetch@rockefeller.edu.
Rockefeller University · USStanford University · US

Funding

Understanding B cell memory in response to diverse virus infectionsU19AI111825 · NIAID · ROCKEFELLER UNIVERSITY · PI RAVETCH, JEFFREY VICTOR · 2014 to 2023
$26.0M
Understanding Human B Cell Responses to Influenza to Improve the Influenza U19AI109946 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI RAVETCH, JEFFREY VICTOR · 2014 to 2018
$9.6M
Regulation of the IgG Fc domain repertoireR01AI139119 · NIAID · STANFORD UNIVERSITY · PI WANG, TAIA · 2019 to 2023
$2.8M
Co-engaging CD23 and BCR for enhanced neutralizing antibody responsesK22AI123478 · NIAID · STANFORD UNIVERSITY · PI WANG, TAIA · 2017 to 2018
$269k
NIAID NIH HHS K22 AI123478NIAID NIH HHS R01 AI139119NIAID NIH HHS U19 AI109946NIAID NIH HHS U19 AI111825
6 · The paper itself

Abstract

A critical factor in the maturation of influenza vaccine responses is the nearly inevitable binding of vaccine antigens by exiting anti-influenza IgGs. These antigen-IgG immune complexes direct the response to immunization by modulating cellular processes that determine antibody and T-cell repertoires: maturation of dendritic cells, processing and presentation of antigens to T cells, trafficking of antigens to the germinal center, and selection of B cells for antibody production. By focusing on the recent advances in the study of the immunomodulatory processes mediated by IgG immune complexes upon influenza vaccination, we discuss a pathway that is critical for modulating the breadth and potency of anti-HA antibody responses and has previously led to the development of strategies to improve influenza vaccine efficacy.

Indexed as

AnimalsAntibodies, ViralAntigen-Antibody ComplexAntigen PresentationB-LymphocytesHumansImmunity, HumoralImmunomodulationInfluenza, HumanInfluenza VaccinesOrthomyxoviridaeOrthomyxoviridae InfectionsT-LymphocytesVaccinationAntibodies, ViralAntigen-Antibody ComplexInfluenza Vaccines

Identifiers

PMID29753885
PMCPMC6141319
OpenAlexW2802154815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.